Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1003-2013Class II

Philips Healthcare Computed Tomography X-Ray System. These devices are whole-body computed tomography (CT)...

Philips North America LLC / initiated 2010-04-05 / Terminated

Philips Healthcare Inc. began a recall of Philips Healthcare Computed Tomography X-Ray System. These devices are whole-body computed tomography (CT) x-ray systems or sub-systems, each with a... on . FDA classified it as Class II and gives the reason as "Philips Healthcare discovered the customer was performing CTDI measurements for facility accreditation and received results that were 15 to 25% higher than Philips protocol parameters stated". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1003-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips North America LLC
Product
Philips Healthcare Computed Tomography X-Ray System. These devices are whole-body computed tomography (CT) x-ray systems or sub-systems, each with a continuously rotating x-ray tube and multi-row detectors enclosed by a gantry. X-ray transmission data acquired and taken at different angles can be reconstructed into cross-sectional images. Each device also includes signal analysis and display equipment, patient and equipment supports, components, and accessories.
Product code
JAK System, X-Ray, Tomography, Computed
Reason for recall
Philips Healthcare discovered the customer was performing CTDI measurements for facility accreditation and received results that were 15 to 25% higher than Philips protocol parameters stated.
FDA root cause
Radiation Control for Health and Safety Act
Action
Philips Healthcare proposed corrective action plan (CAP) is comprised of the following elements: * Updating procedures in manufacturing to verify, either through software calibration or through gage-pin measurement, that A-plane collimation is appropriate to the design specification. It is our understanding that these procedures have been implemented. * For refurbished PET/CT and SPECT/CT systems distributed by Philips, the manufacturing process now requires that CTDI testing be conducted in addition to air testing and that each system meet updated CTDI tolerance limits to be published in the product's instructions for use. * Reassessing and correcting the correlation between air dose and CTDI specifications for all CT systems or sub-systems, resulting in updates of the CTDI specifications (tolerances) to be published in the instructions for use. It is our understanding that this reassessment and correction have been implemented, that the updated CTDI specifications will be made available as new CTDI tolerance tables with the customer information letter to be distributed immediately, and that these updated CTDI specifications will also be distributed as an addendum to the instructions for use manuals to the installed base during the next 12 months. * For all Brilliance CT, Gemini PET/CT, and Precedence SPECT/CT systems, in the installed base as well as in forward production, instructions for field service will be updated to provide clear directions on how to verify that the A-plane collimator has been appropriately adjusted to ensure expected product performance after its replacement and/or the replacement of an x-ray tube. This plan appears to adequately address the problem, and it is hereby approved. For further questions please call (978) 687-1501.
Quantity in commerce
2089 US 4036 ROW
Distribution
Worldwide Distribution including USA (nationwide)
Product codes and lots
Gemini Dual, Gemini 16 Power, Gemini GXL, Gemini LXL, Gemini TF 16, Gemini TF Base/Ready, Gemini TF 64, Gemini TF Big Bore, Precedence SPECT/CT, Brilliance CT (6, 10,16, 16P, 40, 64, and Big Bore), Brilliance iCT, Brilliance iCT SP

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1003-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1003-2013Class IITerminatedVoluntary: Firm initiated